FOLH1 and prostate cancer: <b>Background</b>: This study aimed to assess the impact of PSMA-PET/CT fusion imaging on target volume delineation in prostate cancer RT and to evaluate its effects on dosimetric parameters and PSA response, including intraprostatic boost.